Recall Record

Munich, N/A, Germany

LivaNova Deutschland GmbH recalls

4 recalls recorded since 2018, most recently on 18 October 2024. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)2
Terminated or completed2
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
18 October 2024
Reason
Heart-Lung Machine GUI touchscreen may go dark for 10-15 seconds, safety/performance functions remain operational before reset, control maintained through backup control panel, but second reset may occur, may lead to gas blender standby, then gas blender must be reactivated using user interface on blender, sensors deactivated until new case started; GUI reset can lead to Hypoxia and Hypoperfusion.
Distribution
US Nationwide distribution in the states of CA, VA, GA, IN, NJ, FL, CO, MS, NV.
Initiated
Voluntary: Firm initiated
Recall number
Z-0571-2025

Ongoing Class II Medical devices

Recall started
3 August 2023
Reason
The firm's labeling (Quick Reference Guide) contains incorrect information in the maintenance schedule for the Heater-Cooler device.
Distribution
US Nationwide distribution in the states of CA, IN, GA, NC, TX, AZ, FL, MN, NJ, CO, SC.
Initiated
Voluntary: Firm initiated
Recall number
Z-0073-2024

Terminated Class III Medical devices

Recall started
17 December 2021
Terminated
8 January 2024
Reason
One ferrite ring expected to be installed on centrifugal pump system power cable may not be present.
Distribution
US distribution in states of FL, TX, and NE
Initiated
Voluntary: Firm initiated
Recall number
Z-0787-2022

Terminated Class II Medical devices

Recall started
26 August 2019
Terminated
22 April 2021
Reason
The SCP control Panel rotary knob used to control rotary speed of the pump in the SCP system used as a centrifugal pump during cardiopulmonary bypass may be difficult or impossible to rotate as a result of premature wear of the angle encoder. The loss of function of the angle encoder during bypass may lead to ischemia, stroke, organ damage, arterial tissue injury or reperfusion syndrome.
Distribution
US: FL, GA, IN, KY, MI, MO, NY, OH, PA, SC, TN, TX, VA OUS: Canada - Uzbekistan - Turkey - Tunisia - Taiwan - South Africa - Serbia - Saudi Arabia - Russia - Poland - Mexico - Korea(Rep. of) - India - Hong Kong - Colombia - China - Brazil - Bahrain - Argentina - Algeria - Ita
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2440-2020, Z-2439-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.